nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—KDR—hindlimb—abdominal aortic aneurysm	0.0282	0.0674	CbGeAlD
Regorafenib—TEK—artery—abdominal aortic aneurysm	0.0212	0.0506	CbGeAlD
Regorafenib—FLT1—artery—abdominal aortic aneurysm	0.0205	0.0489	CbGeAlD
Regorafenib—KDR—artery—abdominal aortic aneurysm	0.0173	0.0413	CbGeAlD
Regorafenib—DDR2—connective tissue—abdominal aortic aneurysm	0.0173	0.0412	CbGeAlD
Regorafenib—FLT1—blood plasma—abdominal aortic aneurysm	0.0154	0.0367	CbGeAlD
Regorafenib—UGT1A1—blood plasma—abdominal aortic aneurysm	0.0137	0.0328	CbGeAlD
Regorafenib—KDR—blood plasma—abdominal aortic aneurysm	0.013	0.031	CbGeAlD
Regorafenib—KIT—blood plasma—abdominal aortic aneurysm	0.0115	0.0275	CbGeAlD
Regorafenib—DDR2—spinal cord—abdominal aortic aneurysm	0.0114	0.0273	CbGeAlD
Regorafenib—RET—connective tissue—abdominal aortic aneurysm	0.00928	0.0222	CbGeAlD
Regorafenib—UGT1A9—kidney—abdominal aortic aneurysm	0.00908	0.0217	CbGeAlD
Regorafenib—FGFR2—connective tissue—abdominal aortic aneurysm	0.00882	0.0211	CbGeAlD
Regorafenib—TEK—connective tissue—abdominal aortic aneurysm	0.00846	0.0202	CbGeAlD
Regorafenib—FLT1—connective tissue—abdominal aortic aneurysm	0.00818	0.0195	CbGeAlD
Regorafenib—RAF1—connective tissue—abdominal aortic aneurysm	0.00813	0.0194	CbGeAlD
Regorafenib—RET—kidney—abdominal aortic aneurysm	0.0079	0.0189	CbGeAlD
Regorafenib—PDGFRA—connective tissue—abdominal aortic aneurysm	0.00766	0.0183	CbGeAlD
Regorafenib—FGFR2—kidney—abdominal aortic aneurysm	0.00751	0.0179	CbGeAlD
Regorafenib—CYP2C19—blood plasma—abdominal aortic aneurysm	0.00744	0.0178	CbGeAlD
Regorafenib—TEK—kidney—abdominal aortic aneurysm	0.0072	0.0172	CbGeAlD
Regorafenib—FLT1—kidney—abdominal aortic aneurysm	0.00696	0.0166	CbGeAlD
Regorafenib—RAF1—kidney—abdominal aortic aneurysm	0.00692	0.0165	CbGeAlD
Regorafenib—KDR—connective tissue—abdominal aortic aneurysm	0.00691	0.0165	CbGeAlD
Regorafenib—FGFR1—spinal cord—abdominal aortic aneurysm	0.00688	0.0164	CbGeAlD
Regorafenib—CYP2C8—blood plasma—abdominal aortic aneurysm	0.0065	0.0155	CbGeAlD
Regorafenib—UGT1A1—kidney—abdominal aortic aneurysm	0.00622	0.0149	CbGeAlD
Regorafenib—RET—spinal cord—abdominal aortic aneurysm	0.00615	0.0147	CbGeAlD
Regorafenib—KIT—connective tissue—abdominal aortic aneurysm	0.00612	0.0146	CbGeAlD
Regorafenib—PDGFRB—connective tissue—abdominal aortic aneurysm	0.00598	0.0143	CbGeAlD
Regorafenib—KDR—kidney—abdominal aortic aneurysm	0.00588	0.0141	CbGeAlD
Regorafenib—FGFR2—spinal cord—abdominal aortic aneurysm	0.00585	0.014	CbGeAlD
Regorafenib—CYP2B6—blood plasma—abdominal aortic aneurysm	0.00583	0.0139	CbGeAlD
Regorafenib—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00577	0.0138	CbGeAlD
Regorafenib—TEK—spinal cord—abdominal aortic aneurysm	0.00561	0.0134	CbGeAlD
Regorafenib—FLT1—spinal cord—abdominal aortic aneurysm	0.00542	0.0129	CbGeAlD
Regorafenib—RAF1—spinal cord—abdominal aortic aneurysm	0.00539	0.0129	CbGeAlD
Regorafenib—ABL1—connective tissue—abdominal aortic aneurysm	0.00533	0.0127	CbGeAlD
Regorafenib—KIT—kidney—abdominal aortic aneurysm	0.00521	0.0125	CbGeAlD
Regorafenib—PDGFRB—kidney—abdominal aortic aneurysm	0.00509	0.0122	CbGeAlD
Regorafenib—PDGFRA—spinal cord—abdominal aortic aneurysm	0.00508	0.0121	CbGeAlD
Regorafenib—KDR—spinal cord—abdominal aortic aneurysm	0.00458	0.0109	CbGeAlD
Regorafenib—ABL1—kidney—abdominal aortic aneurysm	0.00454	0.0108	CbGeAlD
Regorafenib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.0044	0.0105	CbGeAlD
Regorafenib—KIT—spinal cord—abdominal aortic aneurysm	0.00406	0.0097	CbGeAlD
Regorafenib—PDGFRB—spinal cord—abdominal aortic aneurysm	0.00397	0.00947	CbGeAlD
Regorafenib—ABL1—spinal cord—abdominal aortic aneurysm	0.00353	0.00844	CbGeAlD
Regorafenib—ABCB1—blood plasma—abdominal aortic aneurysm	0.00311	0.00744	CbGeAlD
Regorafenib—CYP2C8—kidney—abdominal aortic aneurysm	0.00294	0.00703	CbGeAlD
Regorafenib—CYP2B6—kidney—abdominal aortic aneurysm	0.00264	0.00631	CbGeAlD
Regorafenib—ABCG2—spinal cord—abdominal aortic aneurysm	0.00223	0.00532	CbGeAlD
Regorafenib—CYP3A4—kidney—abdominal aortic aneurysm	0.00199	0.00476	CbGeAlD
Regorafenib—ABCB1—kidney—abdominal aortic aneurysm	0.00141	0.00337	CbGeAlD
Regorafenib—ABCB1—spinal cord—abdominal aortic aneurysm	0.0011	0.00262	CbGeAlD
Regorafenib—PDGFRB—Disease—NCF1—abdominal aortic aneurysm	0.000292	0.000503	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00029	0.000499	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000289	0.000496	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000287	0.000494	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000284	0.000489	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000284	0.000489	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000284	0.000489	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000283	0.000487	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NCF1—abdominal aortic aneurysm	0.000282	0.000485	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000282	0.000485	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—MMP9—abdominal aortic aneurysm	0.00028	0.000481	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—NFKB1—abdominal aortic aneurysm	0.000279	0.000481	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000279	0.000479	CbGpPWpGaD
Regorafenib—RAF1—Disease—LDLR—abdominal aortic aneurysm	0.000278	0.000479	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—NOS2—abdominal aortic aneurysm	0.000277	0.000477	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000274	0.000472	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AAAS—abdominal aortic aneurysm	0.000274	0.000472	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000271	0.000466	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.00027	0.000464	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000269	0.000463	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000266	0.000458	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000266	0.000458	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000265	0.000457	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000264	0.000453	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000263	0.000453	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000263	0.000452	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000263	0.000452	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000261	0.000449	CbGpPWpGaD
Regorafenib—RAF1—Disease—NCF1—abdominal aortic aneurysm	0.00026	0.000448	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000257	0.000443	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000257	0.000442	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000256	0.000441	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—MMP9—abdominal aortic aneurysm	0.000256	0.00044	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000255	0.000439	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000253	0.000435	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000248	0.000427	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000248	0.000426	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000244	0.00042	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000243	0.000419	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000243	0.000418	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MMP2—abdominal aortic aneurysm	0.000243	0.000418	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000241	0.000414	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00024	0.000413	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.00024	0.000412	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—LDLR—abdominal aortic aneurysm	0.00024	0.000412	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000234	0.000403	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000234	0.000402	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AAAS—abdominal aortic aneurysm	0.000233	0.000401	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000233	0.0004	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000231	0.000397	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000228	0.000392	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000228	0.000392	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000227	0.000391	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000225	0.000388	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000221	0.000381	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000221	0.00038	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000219	0.000376	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000216	0.000372	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000214	0.000367	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000214	0.000367	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000212	0.000364	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.00021	0.000361	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.00021	0.000361	CbGpPWpGaD
Regorafenib—BRAF—Disease—APOE—abdominal aortic aneurysm	0.000208	0.000358	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000207	0.000357	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000205	0.000353	CbGpPWpGaD
Regorafenib—FGFR2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000205	0.000353	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000205	0.000352	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—LDLR—abdominal aortic aneurysm	0.000203	0.00035	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000202	0.000348	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000201	0.000346	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000199	0.000343	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000199	0.000342	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000199	0.000342	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.000197	0.00034	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000196	0.000337	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000195	0.000335	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS2—abdominal aortic aneurysm	0.000194	0.000334	CbGpPWpGaD
Regorafenib—FGFR2—Disease—APOE—abdominal aortic aneurysm	0.000193	0.000332	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000193	0.000331	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000191	0.000329	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000191	0.000328	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000191	0.000328	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00019	0.000328	CbGpPWpGaD
Regorafenib—KIT—Disease—APOE—abdominal aortic aneurysm	0.00019	0.000326	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000189	0.000324	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000185	0.000318	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000183	0.000314	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—MMP9—abdominal aortic aneurysm	0.000182	0.000314	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000182	0.000314	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000182	0.000314	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000182	0.000313	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000181	0.000312	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—NFKB1—abdominal aortic aneurysm	0.00018	0.000311	CbGpPWpGaD
Regorafenib—FGFR1—Disease—APOE—abdominal aortic aneurysm	0.00018	0.00031	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS2—abdominal aortic aneurysm	0.00018	0.00031	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—APOE—abdominal aortic aneurysm	0.00018	0.000309	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000179	0.000308	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000178	0.000306	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS2—abdominal aortic aneurysm	0.000177	0.000304	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000175	0.000301	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000175	0.000301	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000174	0.0003	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000174	0.0003	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000172	0.000295	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000172	0.000295	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000171	0.000295	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AAAS—abdominal aortic aneurysm	0.000171	0.000294	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS2—abdominal aortic aneurysm	0.000168	0.000289	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS2—abdominal aortic aneurysm	0.000167	0.000288	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000164	0.000283	CbGpPWpGaD
Regorafenib—BRAF—Disease—SERPINE1—abdominal aortic aneurysm	0.000163	0.000281	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000163	0.00028	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000163	0.00028	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—APOE—abdominal aortic aneurysm	0.000162	0.000278	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—NFKB1—abdominal aortic aneurysm	0.000159	0.000274	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000155	0.000266	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000153	0.000263	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000153	0.000263	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000152	0.000262	CbGpPWpGaD
Regorafenib—FGFR2—Disease—SERPINE1—abdominal aortic aneurysm	0.000152	0.000261	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS2—abdominal aortic aneurysm	0.000151	0.000259	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AGT—abdominal aortic aneurysm	0.00015	0.000259	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.00015	0.000258	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—LDLR—abdominal aortic aneurysm	0.000149	0.000256	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000149	0.000256	CbGpPWpGaD
Regorafenib—KIT—Disease—SERPINE1—abdominal aortic aneurysm	0.000149	0.000256	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000147	0.000253	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000147	0.000252	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000146	0.000252	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000146	0.000252	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000146	0.000251	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.000145	0.000249	CbGpPWpGaD
Regorafenib—RAF1—Disease—APOE—abdominal aortic aneurysm	0.000144	0.000248	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000144	0.000248	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000144	0.000247	CbGpPWpGaD
Regorafenib—BRAF—Disease—PTGS2—abdominal aortic aneurysm	0.000143	0.000246	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000142	0.000245	CbGpPWpGaD
Regorafenib—FGFR1—Disease—SERPINE1—abdominal aortic aneurysm	0.000141	0.000243	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—SERPINE1—abdominal aortic aneurysm	0.000141	0.000242	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000138	0.000237	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000136	0.000233	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NFKB1—abdominal aortic aneurysm	0.000135	0.000233	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000135	0.000233	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000134	0.000231	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS2—abdominal aortic aneurysm	0.000134	0.000231	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000134	0.00023	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000133	0.000228	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PTGS2—abdominal aortic aneurysm	0.000132	0.000228	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000131	0.000225	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.00013	0.000224	CbGpPWpGaD
Regorafenib—KIT—Disease—PTGS2—abdominal aortic aneurysm	0.00013	0.000224	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	0.000129	0.000222	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000129	0.000221	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000128	0.000221	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—SERPINE1—abdominal aortic aneurysm	0.000127	0.000218	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AGT—abdominal aortic aneurysm	0.000127	0.000218	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AGT—abdominal aortic aneurysm	0.000127	0.000218	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000126	0.000217	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000126	0.000217	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000126	0.000217	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000126	0.000216	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NFKB1—abdominal aortic aneurysm	0.000124	0.000214	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—APOE—abdominal aortic aneurysm	0.000124	0.000213	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—APOE—abdominal aortic aneurysm	0.000124	0.000213	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000124	0.000213	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PTGS2—abdominal aortic aneurysm	0.000123	0.000212	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PTGS2—abdominal aortic aneurysm	0.000123	0.000212	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000123	0.000211	CbGpPWpGaD
Regorafenib—KIT—Immune System—NFKB1—abdominal aortic aneurysm	0.000122	0.00021	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000122	0.00021	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000119	0.000205	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	0.000118	0.000202	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NFKB1—abdominal aortic aneurysm	0.000116	0.000199	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NFKB1—abdominal aortic aneurysm	0.000116	0.000199	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000116	0.000199	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000116	0.000199	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000114	0.000197	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000114	0.000196	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000113	0.000195	CbGpPWpGaD
Regorafenib—RAF1—Disease—SERPINE1—abdominal aortic aneurysm	0.000113	0.000195	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	0.000113	0.000194	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000112	0.000192	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PTGS2—abdominal aortic aneurysm	0.000111	0.000191	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	0.00011	0.000189	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000109	0.000187	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000108	0.000185	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AGT—abdominal aortic aneurysm	0.000107	0.000185	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000106	0.000183	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000106	0.000182	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000106	0.000182	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—APOE—abdominal aortic aneurysm	0.000105	0.000181	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000104	0.000179	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NFKB1—abdominal aortic aneurysm	0.000104	0.000179	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000103	0.000177	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000103	0.000177	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	0.000103	0.000177	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000102	0.000175	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NFKB1—abdominal aortic aneurysm	0.000102	0.000175	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000101	0.000174	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000101	0.000173	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.89e-05	0.00017	CbGpPWpGaD
Regorafenib—RAF1—Disease—PTGS2—abdominal aortic aneurysm	9.88e-05	0.00017	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	9.86e-05	0.00017	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.52e-05	0.000164	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NFKB1—abdominal aortic aneurysm	9.28e-05	0.00016	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	8.97e-05	0.000154	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.89e-05	0.000153	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.85e-05	0.000152	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.77e-05	0.000151	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.76e-05	0.000151	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.68e-05	0.000149	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PTGS2—abdominal aortic aneurysm	8.5e-05	0.000146	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PTGS2—abdominal aortic aneurysm	8.5e-05	0.000146	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCL2—abdominal aortic aneurysm	8.48e-05	0.000146	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	8.18e-05	0.000141	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MMP9—abdominal aortic aneurysm	8.13e-05	0.00014	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	8.04e-05	0.000138	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.98e-05	0.000137	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	7.92e-05	0.000136	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.9e-05	0.000136	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AGT—abdominal aortic aneurysm	7.88e-05	0.000136	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	7.76e-05	0.000133	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOE—abdominal aortic aneurysm	7.72e-05	0.000133	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.58e-05	0.00013	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—abdominal aortic aneurysm	7.56e-05	0.00013	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.5e-05	0.000129	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—NFKB1—abdominal aortic aneurysm	7.48e-05	0.000129	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—abdominal aortic aneurysm	7.21e-05	0.000124	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.81e-05	0.000117	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	6.77e-05	0.000117	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.73e-05	0.000116	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	6.67e-05	0.000115	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	6.53e-05	0.000112	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.07e-05	0.000104	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6e-05	0.000103	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	5.95e-05	0.000102	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	5.83e-05	0.0001	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	5.81e-05	0.0001	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	5.69e-05	9.79e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	5.43e-05	9.34e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	5.32e-05	9.15e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—abdominal aortic aneurysm	5.29e-05	9.1e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	4.48e-05	7.7e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	4e-05	6.88e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	3.9e-05	6.71e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	3.64e-05	6.27e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	3.58e-05	6.16e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	3.51e-05	6.03e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.4e-05	4.13e-05	CbGpPWpGaD
